Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection.

Espinoza JA, León MA, Céspedes PF, Gómez RS, Canedo-Marroquín G, Riquelme SA, Salazar-Echegarai FJ, Blancou P, Simon T, Anegon I, Lay MK, González PA, Riedel CA, Bueno SM, Kalergis AM.

J Immunol. 2017 Jul 1;199(1):212-223. doi: 10.4049/jimmunol.1601414. Epub 2017 May 31.

2.

Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers.

Simon T, Pogu J, Rémy S, Brau F, Pogu S, Maquigneau M, Fonteneau JF, Poirier N, Vanhove B, Blancho G, Piaggio E, Anegon I, Blancou P.

J Autoimmun. 2017 Jul;81:44-55. doi: 10.1016/j.jaut.2017.03.005. Epub 2017 Mar 23.

PMID:
28342735
3.

Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

White R, Chenciner N, Bonello G, Salas M, Blancou P, Gauduin MC.

Vaccine. 2015 Nov 27;33(48):6914-21. doi: 10.1016/j.vaccine.2013.09.006. Epub 2013 Nov 25.

4.

Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.

Tardif V, Riquelme SA, Remy S, Carreño LJ, Cortés CM, Simon T, Hill M, Louvet C, Riedel CA, Blancou P, Bach JM, Chauveau C, Bueno SM, Anegon I, Kalergis AM.

Eur J Immunol. 2013 Nov;43(11):2832-44. doi: 10.1002/eji.201343600. Epub 2013 Aug 21.

5.

β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells.

Hervé J, Dubreil L, Tardif V, Terme M, Pogu S, Anegon I, Rozec B, Gauthier C, Bach JM, Blancou P.

J Immunol. 2013 Apr 1;190(7):3163-71. doi: 10.4049/jimmunol.1201391. Epub 2013 Feb 18.

6.

Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetes.

Simon T, Pogu S, Tardif V, Rigaud K, Rémy S, Piaggio E, Bach JM, Anegon I, Blancou P.

Eur J Immunol. 2013 Jan;43(1):209-18. doi: 10.1002/eji.201242684. Epub 2012 Dec 11.

7.

Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4.

Hill M, Deghmane AE, Segovia M, Zarantonelli ML, Tilly G, Blancou P, Bériou G, Josien R, Anegon I, Hong E, Ruckly C, Antignac A, El Ghachi M, Boneca IG, Taha MK, Cuturi MC.

PLoS One. 2011;6(10):e23995. doi: 10.1371/journal.pone.0023995. Epub 2011 Oct 27.

8.

Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer.

Simon T, Anegon I, Blancou P.

Immunotherapy. 2011 Apr;3(4 Suppl):15-8. doi: 10.2217/imt.11.43. Review.

PMID:
21524161
9.

Immunoregulatory properties of heme oxygenase-1.

Blancou P, Tardif V, Simon T, Rémy S, Carreño L, Kalergis A, Anegon I.

Methods Mol Biol. 2011;677:247-68. doi: 10.1007/978-1-60761-869-0_18.

PMID:
20941616
10.

Editorial: Heme oxygenase-1 and dendritic cells: what else?

Blancou P, Anegon I.

J Leukoc Biol. 2010 Feb;87(2):185-7. doi: 10.1189/jlb.0909636. No abstract available.

PMID:
20123679
11.

Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity.

Rémy S, Blancou P, Tesson L, Tardif V, Brion R, Royer PJ, Motterlini R, Foresti R, Painchaut M, Pogu S, Gregoire M, Bach JM, Anegon I, Chauveau C.

J Immunol. 2009 Feb 15;182(4):1877-84. doi: 10.4049/jimmunol.0802436.

12.

Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.

Enée E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P.

J Immunol. 2008 Apr 15;180(8):5430-8.

13.

The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.

Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R.

Diabetes. 2008 May;57(5):1312-20. doi: 10.2337/db07-1594. Epub 2008 Feb 27.

14.

Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.

Blancou P, Mallone R, Martinuzzi E, Sévère S, Pogu S, Novelli G, Bruno G, Charbonnel B, Dolz M, Chaillous L, van Endert P, Bach JM.

J Immunol. 2007 Jun 1;178(11):7458-66.

15.

CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.

Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M, Bruno G, Chaillous L, Chatenoud L, Bach JM, van Endert P.

Diabetes. 2007 Mar;56(3):613-21.

16.

HLA class I epitope discovery in type 1 diabetes.

van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R.

Ann N Y Acad Sci. 2006 Oct;1079:190-7.

PMID:
17130554
17.
18.

Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.

Blancou P, Chenciner N, Ho Tsong Fang R, Monceaux V, Cumont MC, Guétard D, Hurtrel B, Wain-Hobson S.

J Virol. 2004 Feb;78(3):1080-92.

19.

The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape.

Blancou P, Chenciner N, Cumont MC, Wain-Hobson S, Hurtrel B, Cheynier R.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13237-42. Epub 2001 Oct 30.

20.

Polio vaccine samples not linked to AIDS.

Blancou P, Vartanian JP, Christopherson C, Chenciner N, Basilico C, Kwok S, Wain-Hobson S.

Nature. 2001 Apr 26;410(6832):1045-6. No abstract available.

PMID:
11323657

Supplemental Content

Loading ...
Support Center